Advisor Resource Council Takes Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Advisor Resource Council bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the third quarter, HoldingsChannel reports. The fund bought 676 shares of the biotechnology company’s stock, valued at approximately $270,000.

Several other large investors have also recently bought and sold shares of AXON. Motley Fool Asset Management LLC boosted its holdings in shares of Axon Enterprise by 238.7% in the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after buying an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. purchased a new position in Axon Enterprise in the 1st quarter valued at $81,630,000. International Assets Investment Management LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at $871,860,000. Vanguard Group Inc. raised its position in Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares during the last quarter. Finally, Swedbank AB purchased a new stake in shares of Axon Enterprise in the first quarter valued at about $39,923,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 2.0 %

Shares of AXON stock opened at $468.75 on Friday. The company has a market capitalization of $35.42 billion, a price-to-earnings ratio of 123.68, a PEG ratio of 10.99 and a beta of 0.94. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The firm has a 50-day moving average price of $409.39 and a 200 day moving average price of $344.81. Axon Enterprise, Inc. has a twelve month low of $212.88 and a twelve month high of $471.00.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. During the same quarter in the previous year, the business posted $0.80 earnings per share. The company’s revenue was up 34.5% on a year-over-year basis. Research analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total transaction of $437,980.00. Following the sale, the director now owns 26,259 shares in the company, valued at $11,500,916.82. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the sale, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the transaction, the director now owns 26,259 shares in the company, valued at $11,500,916.82. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 369,172 shares of company stock valued at $136,270,842. Company insiders own 5.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on AXON shares. Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective on the stock. Northland Securities increased their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Bank of America started coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 target price on the stock. Robert W. Baird increased their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday. Finally, The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $392.85.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.